All MM Janssen HME Forum webinars

Practical considerations around CAR T-cell therapies for patients with multiple myeloma

12 May 2022 - 48 Minutes

Faculty

Michel Delforge

Paula Rodriguez Otero

Max Topp

EM-78417

Bridging the gap between patient and clinician perspectives in myeloma care

10 May 2022 - 46 Minutes

Faculty

Mohamad Mohty

Solène Clavreul

EM-78406

How do you plan the patient journey at diagnosis for patients with multiple myeloma?

28 April 2022 - 45 Minutes

Faculty

María Victoria Mateos

Philippe Moreau

Inger Nijhof

EM-78398

Is cure attainable in patients with multiple myeloma?

26 April 2022 - 45 Minutes

Faculty

Mohamad Mohty

Rakesh Popat

EM-78392

Transforming the landscape of multiple myeloma (MM) with CAR T-cell therapies

12 March 2022 - 46 Minutes

Faculty

Philippe Moreau

Kwee Yong

Inger Nijhof

EM-89024

Patient management strategies with CAR T-cell therapies in multiple myeloma: How to prepare the patient

10 March 2022 - 52 Minutes

Faculty

Paula Rodriguez Otero

Salomon Manier

Jaime Gállego Pérez-Larraya

EM-78389

Is fixed-duration therapy realistic in managing patients with multiple myeloma?

8 March 2022 - 47 Minutes

Faculty

Mohamad Mohty

Philippe Moreau

EM-78385

Is ASCT still the standard of care in fit patients with newly-diagnosed multiple myeloma?

24 February 2022 - 46 Minutes

Faculty

Xavier Leleu

Mohamad Mohty

What is the role of MRD assessment in multiple myeloma?

15 February 2022 - 61 Minutes

Faculty

María Victoria Mateos

Bruno Paiva

Elena Zamagni

Noemi Puig

EM-84231

$Sequencing options today and in the future for patients with relapsed/refractory multiple myeloma$

1 February 2022 - 47 Minutes

Faculty

Mohamad Mohty

Karthik Ramasamy

EM-78378

1
2
3